Hybrid strategy of drug-eluting stent and drug-coated balloon in the treatment of de novo coronary artery disease: 1-year clinical outcomes
A hybrid strategy of DES and DCB for the treatment of <i>de novo</i> coronary artery lesions appears to be feasible and clinically safe according to the 1-year outcomes.
Authors
- Beni Isman Rusani (ORCID: https://orcid.org/0000-0001-7219-4754)
- Aslannif Roslan (ORCID: https://orcid.org/0000-0003-0551-5495)
- Kumara Gurupparan Ganesan
- Hui Beng Koh (ORCID: https://orcid.org/0000-0002-2156-1611)
- Faten Aqilah Aris
- Chan Ho Thum (ORCID: https://orcid.org/0009-0004-9010-3309)
- Ganapathi Palaniappan (ORCID: https://orcid.org/0000-0001-8196-2639)
- Hafidz Abd Hadi
- Zulaikha Zainal
- Jassie Teo
- Steven Wong
- Khai Chih Teh
- Nor Faiqah Ahmad
- Tawfeq Mohd Noor
Institutions
- National Heart Institute (MY)
Publication Details
- Journal
- AsiaIntervention
- Published
- 2024-09-01
- DOI
- https://doi.org/10.4244/aij-d-23-00066
- Citations
- 3
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.72